Skip to content

Hatch-Waxman Disputes Regarding Boniva

Represented Hoffmann-La Roche Inc. and Genentech, Inc. in multiple Hatch-Waxman suits to prevent generic drug companies from launching at-risk generic versions of the branded osteoporosis drug Boniva®. Secured a critical claim construction victory and three preliminary injunctions on patent covering the active ingredient.